LSE:ULVR 23 January 2026 - 25 February 2026

Unilever shares rose 0.3% in early London trading after CEO Fernando Fernandez disclosed the sale of 17,327 shares following a performance award vesting. Investors await comments at the CAGNY conference and Unilever’s Q1 update on April 30. The company recently signaled 2026 sales growth at the low end of its target range.

Unilever shares rose 0.2% to 5,176 pence in early London trading Tuesday after a 1.6% drop Monday. Deutsche Bank downgraded the stock to “hold,” citing valuation concerns after a recent rally. Investors are awaiting Unilever’s full-year results, due Feb. 12.

Unilever shares fell 0.7% to 5,214 pence in early London trading after Deutsche Bank downgraded the stock to “hold” from “buy,” citing stretched valuation. The bank kept its target price at 5,150p, below the current level. Investors await Unilever’s results update on Feb. 12 for volume and margin guidance.

Unilever shares fell 0.5% to 5,223 pence in early London trading Friday, pulling back from a 12-month high reached Thursday. A U.S. filing showed the company issued 4.2 million new shares for employee stock awards, bringing the total to over 2.18 billion. Investors await Unilever’s full-year results on Feb. 12 and an investor conference on Feb. 17.

Unilever shares fell 0.25% to 5,165 pence in early London trading Thursday, underperforming a steady FTSE 100. Investors are focused on the company’s Feb. 12 full-year results, with consensus forecasts showing 3.5% underlying sales growth for 2025. The company is under scrutiny after shedding its ice cream division and as analysts watch for volume trends.

Unilever shares rose 2.25% to 5,051.5 pence in early London trading Monday, outperforming a 0.4% drop in the FTSE 100 as mining and defence stocks fell. The company faces boardroom tensions over its former Ben & Jerry’s unit and upcoming earnings on Feb. 12. Asian stocks and commodities also declined, while the dollar surged after Trump’s Fed chair pick.

Unilever shares closed Friday up 1.5% at 4,940.5 pence in London, outperforming the FTSE 100. Around 3.1 million shares traded. The company’s full-year results are due Feb. 12, with a court fight over Ben & Jerry’s board ongoing. Unilever also agreed to sell its Home Care business in Colombia and Ecuador to Alicorp, pending regulatory approval.

Unilever shares slipped 0.3% to 4,852 pence in early London trading after the company agreed to sell its Home Care business in Colombia and Ecuador to Alicorp. The sale, which includes brands like Fab and Deja, awaits regulatory approval. Financial terms were not disclosed. Investors are focused on Unilever’s Feb. 12 results for updates on growth and cash returns.

Unilever shares fell 0.45% to 4,793.75 pence in early London trading after the company agreed to sell its home care business in Colombia and Ecuador to Alicorp. No price or timeline was disclosed. The deal includes brands such as Fab, 3D, Aromatel, and Deja and awaits regulatory approval. Investors are watching for further portfolio changes ahead of Unilever’s mid-February earnings.

Unilever shares slipped 0.1% to 4,860 pence in early London trading Monday, ahead of its Feb. 12 results and updated guidance. The stock moved in a narrow range as investors awaited the U.S. Federal Reserve’s policy decision later this week. Unilever expects 2025 underlying sales growth of 3–5% and will classify ice cream as discontinued in upcoming results. European stocks edged higher, with the STOXX 600 up 0.06%.

Unilever shares rose 0.7% to 4,849 pence in early London trading after Barclays raised its target price, while Jefferies kept a Sell rating. The STOXX 600 slipped 0.2% as investors awaited PMI data and monitored U.S.-Europe trade tensions. Unilever’s next earnings report is due Feb. 12.